Literature DB >> 29683546

Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.

M Süße1, M Hannich2, A Petersmann2, S Zylla2, M Pietzner2, M Nauck2, A Dressel3.   

Abstract

BACKGROUND AND
PURPOSE: The gold standard for detection of intrathecal immunoglobulin synthesis is the measurement of oligoclonal bands (OCB). In the diagnosis of multiple sclerosis, the kappa free light chains (KFLC) index has a similar sensitivity and specificity as OCB. This study investigated whether determination of the KFLC index could be used to predict the presence of OCB.
METHODS: The KFLC index was determined prospectively from 295 paired serum and cerebrospinal fluid samples. KFLC were determined by nephelometry using the N Latex FLC kappa kit (Siemens Healthcare Diagnostics Products GmbH) on the BN Prospec analyzer (Siemens Healthcare Diagnostics Products GmbH) (cohort I). A cut-off value was determined using receiver operating characteristic analysis in relation to OCB positivity. These results were validated prospectively in 96 samples (cohort II) as well as retrospectively in samples of 46 patients known to be OCB positive (cohort III). We also compared the agreement of two commercially available nephelometric KFLC assays.
RESULTS: In cohort I, a KFLC index of 3.61 yielded 100% sensitivity and 88% specificity. Prospective validation of this cut-off value in cohort II showed 92% sensitivity and 96% specificity. In cohort III, a sensitivity of 93% was achieved. Comparison of Siemens and Binding Site (Birmingham, UK) assays revealed good agreement (r2  = 0.86).
CONCLUSIONS: The KFLC index with a cut-off value of 3.61 had high diagnostic accuracy to predict immunoglobulin G synthesis via OCB analysis. Determination of the KFLC index provided a quantitative parameter that could be used as an initial diagnostic step in inflammatory central nervous system disorders before measuring OCB.
© 2018 EAN.

Entities:  

Keywords:  cerebrospinal fluid analysis; intrathecal immunoglobulin synthesis; kappa free light chains; oligoclonal bands

Mesh:

Substances:

Year:  2018        PMID: 29683546     DOI: 10.1111/ene.13667

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

1.  Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements.

Authors:  Patrizia Natali; Roberta Bedin; Gaetano Bernardi; Elena Corsini; Eleonora Cocco; Lucia Schirru; Ilaria Crespi; Marta Lamonaca; Arianna Sala; Cinzia Nicolò; Massimiliano Di Filippo; Alfredo Villa; Viviana Nociti; Teresa De Michele; Paola Cavalla; Paola Caropreso; Francesca Vitetta; Maria Rosaria Cucinelli; Matteo Gastaldi; Tommaso Trenti; Patrizia Sola; Diana Ferraro
Journal:  Biomolecules       Date:  2022-05-07

2.  Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Authors:  C E Leurs; Ham Twaalfhoven; B I Lissenberg-Witte; V van Pesch; I Dujmovic; J Drulovic; M Castellazzi; T Bellini; M Pugliatti; J Kuhle; L M Villar; J C Alvarez-Cermeño; R Alvarez-Lafuente; H Hegen; F Deisenhammer; L M Walchhofer; E Thouvenot; M Comabella; X Montalban; L Vécsei; C Rajda; D Galimberti; E Scarpini; A Altintas; K Rejdak; J L Frederiksen; G Pihl-Jensen; Peh Jensen; M Khalil; M M Voortman; F Fazekas; A Saiz; D La Puma; M Vercammen; L Vanopdenbosch; Bmj Uitdehaag; J Killestein; C Bridel; C Teunissen
Journal:  Mult Scler       Date:  2019-05-08       Impact factor: 6.312

3.  The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.

Authors:  Philipp Schwenkenbecher; Franz Felix Konen; Ulrich Wurster; Konstantin Fritz Jendretzky; Stefan Gingele; Kurt-Wolfram Sühs; Refik Pul; Torsten Witte; Martin Stangel; Thomas Skripuletz
Journal:  Int J Mol Sci       Date:  2018-11-29       Impact factor: 5.923

4.  Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy.

Authors:  Marie Süße; Fritz Feistner; Matthias Grothe; Matthias Nauck; Alexander Dressel; Malte Johannes Hannich
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-09-18

5.  Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern.

Authors:  Malte Johannes Hannich; Alexander Dressel; Kathrin Budde; Astrid Petersmann; Matthias Nauck; Marie Süße
Journal:  Cells       Date:  2021-03-11       Impact factor: 6.600

Review 6.  The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Kurt-Wolfram Sühs; Hayrettin Tumani; Marie Süße; Thomas Skripuletz
Journal:  Cells       Date:  2021-11-06       Impact factor: 6.600

Review 7.  The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid.

Authors:  Franz F Konen; Philipp Schwenkenbecher; Ulrich Wurster; Konstantin F Jendretzky; Nora Möhn; Stefan Gingele; Kurt-Wolfram Sühs; Malte J Hannich; Matthias Grothe; Torsten Witte; Martin Stangel; Marie Süße; Thomas Skripuletz
Journal:  J Cent Nerv Syst Dis       Date:  2021-11-19

8.  Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Torsten Witte; Kurt-Wolfram Sühs; Matthias Grothe; Malte Johannes Hannich; Marie Süße; Thomas Skripuletz
Journal:  Brain Sci       Date:  2022-04-03

9.  The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation.

Authors:  Franz Felix Konen; Ulrich Wurster; Torsten Witte; Konstantin Fritz Jendretzky; Stefan Gingele; Hayrettin Tumani; Kurt-Wolfram Sühs; Martin Stangel; Philipp Schwenkenbecher; Thomas Skripuletz
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

10.  Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment.

Authors:  Marie Süße; Franz Felix Konen; Philipp Schwenkenbecher; Kathrin Budde; Matthias Nauck; Matthias Grothe; Malte Johannes Hannich; Thomas Skripuletz
Journal:  Diagnostics (Basel)       Date:  2022-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.